Hemosol

HML-T

0.00
0.00 (0.00%)
This company is not ACTIVE.

Analysis and Opinions about HML-T

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
August 9, 2005
This could be a time when money moves back into the health care. Usually the small cap biotech stocks, such as Biovale (BVF-T), Patheon (PTI-T), MDS (MDS-T), etc. move together. Don't just buy one, buy 3 or 4 of them. This one is a pretty thin trader, so would stay away from it.
Show full opinionHide full opinion
Hemosol (HML-T)
August 9, 2005
This could be a time when money moves back into the health care. Usually the small cap biotech stocks, such as Biovale (BVF-T), Patheon (PTI-T), MDS (MDS-T), etc. move together. Don't just buy one, buy 3 or 4 of them. This one is a pretty thin trader, so would stay away from it.
DON'T BUY
DON'T BUY
June 13, 2005
Consolidated stock at 4 to 1 to meet Nasdaq requirements. Markets hate reverse consolidations. Typically it's not a good sign as it means you've got too many shares outstanding. Not a great company, so wouldn't expect a whole lot from this company in the future.
Show full opinionHide full opinion
Hemosol (HML-T)
June 13, 2005
Consolidated stock at 4 to 1 to meet Nasdaq requirements. Markets hate reverse consolidations. Typically it's not a good sign as it means you've got too many shares outstanding. Not a great company, so wouldn't expect a whole lot from this company in the future.
VAGUE
VAGUE
February 9, 2004
Speculative future.
Show full opinionHide full opinion
Hemosol (HML-T)
February 9, 2004
Speculative future.
BUY
BUY
January 28, 2004
It will expire again, company has run out of money many times. Take money out, while money is on the table.
Show full opinionHide full opinion
Hemosol (HML-T)
January 28, 2004
It will expire again, company has run out of money many times. Take money out, while money is on the table.
SELL
SELL
January 26, 2004
Basically, you are paying for an option. The company has run out of money many times and they continue to have regulatory problems with their product.
Show full opinionHide full opinion
Hemosol (HML-T)
January 26, 2004
Basically, you are paying for an option. The company has run out of money many times and they continue to have regulatory problems with their product.
DON'T BUY
DON'T BUY
December 15, 2003
Built a nice plant in Mississauga, but found they had trouble with their blood substitute. Now a speculative stock.
Show full opinionHide full opinion
Hemosol (HML-T)
December 15, 2003
Built a nice plant in Mississauga, but found they had trouble with their blood substitute. Now a speculative stock.
DON'T BUY
DON'T BUY
December 8, 2003
Have made arrangements with another biotech company by contracting for part of their facility. Should be getting some revenues. Not a fan.
Show full opinionHide full opinion
Hemosol (HML-T)
December 8, 2003
Have made arrangements with another biotech company by contracting for part of their facility. Should be getting some revenues. Not a fan.
DON'T BUY
DON'T BUY
December 8, 2003
A speculative play. Hemalink stalled in face two clinical trials. Build a plant. Limited visibility going forward.
Show full opinionHide full opinion
Hemosol (HML-T)
December 8, 2003
A speculative play. Hemalink stalled in face two clinical trials. Build a plant. Limited visibility going forward.
DON'T BUY
DON'T BUY
September 5, 2003
Ran into trouble with their lead product. Down to about $900,000 in cash. The company is on life support.
Show full opinionHide full opinion
Hemosol (HML-T)
September 5, 2003
Ran into trouble with their lead product. Down to about $900,000 in cash. The company is on life support.
DON'T BUY
DON'T BUY
March 31, 2003
Very speculative. FDA trials didn't go well.
Show full opinionHide full opinion
Hemosol (HML-T)
March 31, 2003
Very speculative. FDA trials didn't go well.
DON'T BUY
DON'T BUY
March 17, 2003
A lot of problems. May not survive.
Show full opinionHide full opinion
Hemosol (HML-T)
March 17, 2003
A lot of problems. May not survive.
DON'T BUY
DON'T BUY
January 14, 2003
A long way from being a mature company with mature products. Speculative.
Show full opinionHide full opinion
Hemosol (HML-T)
January 14, 2003
A long way from being a mature company with mature products. Speculative.
DON'T BUY
DON'T BUY
January 14, 2003
Never seems to get it together.
Show full opinionHide full opinion
Hemosol (HML-T)
January 14, 2003
Never seems to get it together.
DON'T BUY
DON'T BUY
December 5, 2002
Worst is behind them. Would prefer owning through MDS.
Show full opinionHide full opinion
Hemosol (HML-T)
December 5, 2002
Worst is behind them. Would prefer owning through MDS.
WEAK BUY
WEAK BUY
November 7, 2002
OK for a long term hold. Buy on weakness.
Show full opinionHide full opinion
Hemosol (HML-T)
November 7, 2002
OK for a long term hold. Buy on weakness.
DON'T BUY
DON'T BUY
November 1, 2002
Has some problems. Cash position is down to one year. If they issue stocks to rais cash, it will dilute these shares further.
Show full opinionHide full opinion
Hemosol (HML-T)
November 1, 2002
Has some problems. Cash position is down to one year. If they issue stocks to rais cash, it will dilute these shares further.
DON'T BUY
DON'T BUY
October 2, 2002
Very risky situation. May have to dilute stock by issuing more shares.
Show full opinionHide full opinion
Hemosol (HML-T)
October 2, 2002
Very risky situation. May have to dilute stock by issuing more shares.
DON'T BUY
DON'T BUY
September 20, 2002
Could run out of cash.
Show full opinionHide full opinion
Hemosol (HML-T)
September 20, 2002
Could run out of cash.
DON'T BUY
DON'T BUY
August 20, 2002
Had delays in getting product out. A lot of cash. Risky unless you buy several small pharmaceuticals to spread the risk.
Show full opinionHide full opinion
Hemosol (HML-T)
August 20, 2002
Had delays in getting product out. A lot of cash. Risky unless you buy several small pharmaceuticals to spread the risk.
DON'T BUY
DON'T BUY
August 19, 2002
Has cash burn and has to raise money. Speculative.
Show full opinionHide full opinion
Hemosol (HML-T)
August 19, 2002
Has cash burn and has to raise money. Speculative.
DON'T BUY
DON'T BUY
May 2, 2002
Have had a tough time getting approval. Competition is growing. Future is uncertain.
Show full opinionHide full opinion
Hemosol (HML-T)
May 2, 2002
Have had a tough time getting approval. Competition is growing. Future is uncertain.
DON'T BUY
DON'T BUY
Hemosol (HML-T)
April 29, 2002
Hard to like.
DON'T BUY
DON'T BUY
April 25, 2002
Disappointed with their product results. High burn rate.
Show full opinionHide full opinion
Hemosol (HML-T)
April 25, 2002
Disappointed with their product results. High burn rate.
DON'T BUY
DON'T BUY
April 18, 2002
Has disappointed. Not convinced about the needs for blood substitute.
Show full opinionHide full opinion
Hemosol (HML-T)
April 18, 2002
Has disappointed. Not convinced about the needs for blood substitute.
DON'T BUY
DON'T BUY
April 3, 2002
Treat as a trading stock. No value right now.
Show full opinionHide full opinion
Hemosol (HML-T)
April 3, 2002
Treat as a trading stock. No value right now.
DON'T BUY
DON'T BUY
April 2, 2002
Only has one drug. Needds more diversification.
Show full opinionHide full opinion
Hemosol (HML-T)
April 2, 2002
Only has one drug. Needds more diversification.
DON'T BUY
DON'T BUY
March 21, 2002
Approval of Hemolink was denied. No revenues or earnings.
Show full opinionHide full opinion
Hemosol (HML-T)
March 21, 2002
Approval of Hemolink was denied. No revenues or earnings.
DON'T BUY
DON'T BUY
March 21, 2002
Too much competition.
Show full opinionHide full opinion
Hemosol (HML-T)
March 21, 2002
Too much competition.
BUY
BUY
March 20, 2002
At a good price and a good buy for an aggressive investor.
Show full opinionHide full opinion
Hemosol (HML-T)
March 20, 2002
At a good price and a good buy for an aggressive investor.
DON'T BUY
DON'T BUY
February 19, 2002
A one trick pony. Speculative.
Show full opinionHide full opinion
Hemosol (HML-T)
February 19, 2002
A one trick pony. Speculative.
DON'T BUY
DON'T BUY
January 23, 2002
Have ahd difficulties in their trials. May have a weak cash position.
Show full opinionHide full opinion
Hemosol (HML-T)
January 23, 2002
Have ahd difficulties in their trials. May have a weak cash position.
DON'T BUY
DON'T BUY
January 9, 2002
Starting to move up, but prefers to wait for the product to start selling.
Show full opinionHide full opinion
Hemosol (HML-T)
January 9, 2002
Starting to move up, but prefers to wait for the product to start selling.
BUY
BUY
December 31, 2001
A long term situation, but expects it will do OK.
Show full opinionHide full opinion
Hemosol (HML-T)
December 31, 2001
A long term situation, but expects it will do OK.
BUY
BUY
December 28, 2001
Sees it going up. Use a $6.90 stop loss. Expects it to get to $8.75 at which time it should be looked at again.
Show full opinionHide full opinion
Hemosol (HML-T)
December 28, 2001
Sees it going up. Use a $6.90 stop loss. Expects it to get to $8.75 at which time it should be looked at again.
WAIT
WAIT
December 21, 2001
A lot of competition in blood substitutes.
Show full opinionHide full opinion
Hemosol (HML-T)
December 21, 2001
A lot of competition in blood substitutes.
DON'T BUY
DON'T BUY
December 6, 2001
Prefers other companies that have earnings. Might buy at $3.
Show full opinionHide full opinion
Hemosol (HML-T)
December 6, 2001
Prefers other companies that have earnings. Might buy at $3.
DON'T BUY
DON'T BUY
November 28, 2001
Wait for FDA approval.
Show full opinionHide full opinion
Hemosol (HML-T)
November 28, 2001
Wait for FDA approval.
DON'T BUY
DON'T BUY
November 27, 2001
If you own, hold.
Show full opinionHide full opinion
Hemosol (HML-T)
November 27, 2001
If you own, hold.
DON'T BUY
DON'T BUY
November 26, 2001
Watch how the trials go.
Show full opinionHide full opinion
Hemosol (HML-T)
November 26, 2001
Watch how the trials go.
WEAK BUY
WEAK BUY
November 22, 2001
Analysts are expecting a large upside. Will take time to get through the FDA phases.
Show full opinionHide full opinion
Hemosol (HML-T)
November 22, 2001
Analysts are expecting a large upside. Will take time to get through the FDA phases.
DON'T BUY
DON'T BUY
November 5, 2001
Wait for FDA approval to go through. Will be a good product.
Show full opinionHide full opinion
Hemosol (HML-T)
November 5, 2001
Wait for FDA approval to go through. Will be a good product.
BUY
BUY
October 25, 2001
A worthwhile stock to own a little bit. At a good price.
Show full opinionHide full opinion
Hemosol (HML-T)
October 25, 2001
A worthwhile stock to own a little bit. At a good price.